Literature DB >> 21815910

A population-based investigation of the autoantibody profile in mothers of children with atrioventricular block.

S Salomonsson1, V Dzikaite, E Zeffer, H Eliasson, A Ambrosi, G Bergman, E Fernlund, E Theander, A Ohman, A Rydberg, T Skogh, S Wållberg-Jonsson, A Elfving, M Fored, A Ekbom, U Lundström, M Mellander, O Winqvist, S-E Sonesson, F Gadler, A Jonzon, M Wahren-Herlenius.   

Abstract

The objective of the study was to investigate the antigen specificity and occurrence of individual autoantibodies in mothers of children diagnosed with atrioventricular (AV) block in a nation-wide setting. Patients with AV block detected before 15 years of age were identified using national quality registries as well as a network of pediatric and adult cardiologists and rheumatologists at the six university hospitals in Sweden. Patients with gross heart malformations, surgically or infectiously induced blocks were excluded. Blood samples were obtained from the mothers and maternal autoantibody profile, including the occurrence of antibodies against Ro52, Ro60, La, SmB, SmD, RNP-70k, RNP-A, RNP-C, CENP-C, Scl-70, Jo-1, ribosomal RNP and histones was investigated in 193 mothers of children with AV block by immunoblotting and ELISA. Autoantibody reactivity was detected in 48% (93/193) of the mothers of children with AV block. In autoantibody-positive mothers, the vast majority, 95% (88/93), had antibodies against Ro52, while 63% (59/93) had autoantibodies to Ro60 and 58% (54/93) had autoantibodies to La. In addition, 13% (12/93) of the autoantibody-positive mothers had antibodies to other investigated antigens besides Ro52, Ro60 and La, and of these anti-histone antibodies were most commonly represented, detected in 8% (7/93) of the mothers. In conclusion, this Swedish population-based study confirms that maternal autoantibodies may associate with heart block in the child. Further, our data demonstrate a dominant role of Ro52 antibodies in association with AV block.
© 2011 The Authors. Scandinavian Journal of Immunology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21815910     DOI: 10.1111/j.1365-3083.2011.02610.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  10 in total

Review 1.  The clinical spectrum of autoimmune congenital heart block.

Authors:  Pilar Brito-Zerón; Peter M Izmirly; Manuel Ramos-Casals; Jill P Buyon; Munther A Khamashta
Journal:  Nat Rev Rheumatol       Date:  2015-03-24       Impact factor: 20.543

2.  Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus.

Authors:  Joanne H Reed; Robert M Clancy; Kristen H Lee; Amit Saxena; Peter M Izmirly; Jill P Buyon
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-09       Impact factor: 4.794

3.  Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.

Authors:  Marta Tonello; Ariela Hoxha; Elena Mattia; Alessandra Zambon; Silvia Visentin; Alessia Cerutti; Anna Ghirardello; Ornella Milanesi; Amelia Ruffatti
Journal:  Clin Rheumatol       Date:  2017-02-15       Impact factor: 2.980

Review 4.  A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.

Authors:  Adrian Y S Lee
Journal:  Rheumatol Int       Date:  2017-04-17       Impact factor: 2.631

5.  Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model.

Authors:  A Hoxha; A Ruffatti; A Ambrosi; V Ottosson; M Hedlund; L Ottosson; M Anandapadamanaban; M Sunnerhagen; S-E Sonesson; M Wahren-Herlenius
Journal:  Clin Exp Immunol       Date:  2016-09-13       Impact factor: 4.330

Review 6.  Congenital heart block: evidence for a pathogenic role of maternal autoantibodies.

Authors:  Aurélie Ambrosi; Marie Wahren-Herlenius
Journal:  Arthritis Res Ther       Date:  2012-04-26       Impact factor: 5.156

7.  A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene.

Authors:  Cinzia Ciccacci; Carlo Perricone; Fulvia Ceccarelli; Sara Rufini; Davide Di Fusco; Cristiano Alessandri; Francesca Romana Spinelli; Enrica Cipriano; Giuseppe Novelli; Guido Valesini; Paola Borgiani; Fabrizio Conti
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

Review 8.  Autoimmune-associated Congenital Heart Block: A New Insight in Fetal Life.

Authors:  Kai-Yu Zhou; Yi-Min Hua
Journal:  Chin Med J (Engl)       Date:  2017-12-05       Impact factor: 2.628

9.  Environmental and lifestyle factors influencing risk of congenital heart block during pregnancy in anti-Ro/SSA-positive women.

Authors:  Sabrina Meisgen; Joanna Tingström; Amanda Skog Andreasson; Sven-Erik Sonesson; Ingrid Kockum; Marie Wahren-Herlenius
Journal:  RMD Open       Date:  2017-09-07

10.  Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function.

Authors:  Sabrina Meisgen; Malin Hedlund; Aurelie Ambrosi; Lasse Folkersen; Vijole Ottosson; David Forsberg; Gudny Ella Thorlacius; Luca Biavati; Linn Strandberg; Johannes Mofors; Daniel Ramskold; Sabrina Ruhrmann; Lauro Meneghel; William Nyberg; Alexander Espinosa; Robert Murray Hamilton; Anders Franco-Cereceda; Anders Hamsten; Tomas Olsson; Lois Greene; Per Eriksson; Kristina Gemzell-Danielsson; Stina Salomonsson; Vijay K Kuchroo; Eric Herlenius; Ingrid Kockum; Sven-Erik Sonesson; Marie Wahren-Herlenius
Journal:  Ann Rheum Dis       Date:  2022-04-25       Impact factor: 27.973

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.